Advertisement

Future Prospects and Vision

  • Ajeet KaushikEmail author
  • Babak Kateb
  • Madhavan Nair
Chapter
  • 364 Downloads

Abstract

The nano-enabled approached for (a) nanoparticles surface chemistry needed to bind with therapeutic agent, (b) stimuli-response drug delivery and site-specific release of therapeutic agent, (c) development of pharmacological relevant personalized nanomedicine, (d) bioinformatics to manage a targeted diseases, (e) smart sensing system for diagnostics have been described in this book. However, there is a considerable explore novel biocompatible nanostructures to develop nanoformulation (NF) exhibit targeted delivery, better efficacy, and no adverse effects. Beside this novel nanostructures are also in demand to fabricate miniaturized sensing system for POC applications for rapid diagnostics needed for timey therapeutics. The state-of-the-art of advancements in personalized nanotherapeutics, related challenged, potentials future vision are discussed briefly in this chapter

Keywords

Personalized nanomedicine POC systems Health care management 

Notes

Acknowledgments

Authors acknowledge NIH grants namely RO1DA027049, RO1DA034547, RO1-DA037838, RO1DA040537, and RO1DA042706.

Competing Financial Interests

Authors declare no conflict of interest

References

  1. 1.
    Fadeel B, Garcia-Bennett AE. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev. 2010;62(3):362–74.CrossRefPubMedGoogle Scholar
  2. 2.
    Thanh NTK, Green LAW. Functionalisation of nanoparticles for biomedical applications. Nano Today. 2010;5(3):213–30.CrossRefGoogle Scholar
  3. 3.
    Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18):3995–4021.CrossRefPubMedGoogle Scholar
  4. 4.
    Kaushik A, Jayant RD, Sagar V, Nair M. The potential of magneto-electric nanocarriers for drug delivery. Expert Opin Drug Deliv. 2014;11(10):1635–46.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Ruiz A, Nair M, Kaushik A. Recent update in NanoCure of NeuroAIDS. Sci Lett J. 2015;4:172.Google Scholar
  6. 6.
    Nair M, Jayant RD, Kaushik A, Sagar V. Getting into the brain: potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev. 2016;103:202–17.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Kaushik A, Jayant RD, Nair M. Advancements in nano-enabled therapeutics for neuroHIV management. Int J Nanomedicine. 2016;11:4317.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kaushik A, Jayant RD, Nikkhah-Moshaie R, Bhardwaj V, Roy U, Huang Z, Ruiz A, Yndart A, Atluri V, El-Hage N, Khalili K. Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers. Scientific Rep. 2016;6:25309.CrossRefGoogle Scholar
  9. 9.
    Jayant RD, Atluri VS, Agudelo M, Sagar V, Kaushik A, Nair M. Sustained-release nanoART formulation for the treatment of neuroAIDS. Int J Nanomedicine. 2015;10:1077.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Nair M, Guduru R, Liang P, Hong J, Sagar V, Khizroev S. Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers. Nat Commun. 2013;4:1707.CrossRefPubMedGoogle Scholar
  11. 11.
    Tomitaka A, Arami H, Raymond A, Yndart A, Kaushik A, Jayant RD, Takemura Y, Cai Y, Toborek M, Nair M. Development of magneto-plasmonic nanoparticles for multimodal image-guided therapy to the brain. Nanoscale. 2017;9(2):764–73.CrossRefPubMedGoogle Scholar
  12. 12.
    Kaushik A, Nikkhah-Moshaie R, Sinha R, Bhardwaj V, Atluri V, Jayant RD, Yndart A, Kateb B, Pala N, Nair M. Investigation of ac-magnetic field stimulated nanoelectroporation of magneto-electric nano-drug-carrier inside CNS cells. Scientific Rep. 2017;7:45663.CrossRefGoogle Scholar
  13. 13.
    Vashist A, Kaushik A, Vashist A, Jayant RD, Tomitaka A, Ahmad S, Gupta YK, Nair M. Recent trends on hydrogel based drug delivery systems for infectious diseases. Biomater Sci. 2016;4(11):1535–53.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kaushik A, Tiwari S, Jayant RD, Vashist A, Nikkhah-Moshaie R, El-Hage N, Nair M. Electrochemical biosensors for early stage Zika diagnostics. Trends Biotechnol. 2017;35(4):308–17.CrossRefPubMedGoogle Scholar
  15. 15.
    Kaushik A, Tiwari S, Jayant RD, Marty A, Nair M. Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosens Bioelectron. 2016;75:254–72.CrossRefPubMedGoogle Scholar
  16. 16.
    Kaushik A, Jayant RD, Tiwari S, Vashist A, Nair M. Nano-biosensors to detect beta-amyloid for Alzheimer’s disease management. Biosens Bioelectron. 2016;80:273–87.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Kaushik A, Dixit CK. Nanobiotechnology for sensing applications: from lab to field. Oakville, Canada: Apple Academic; 2016.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Center for Personalized Nanomedicine, Institute of Neuro immune Pharmacology, Department of ImmunologyHerbert Wertheim College of Medicine, Florida International UniversityMiamiUSA
  2. 2.National Center for NanoBioElectronicsWest, HollywoodUSA
  3. 3.California Neurosurgical InstituteLos AngelesUSA
  4. 4.Brain Mapping FoundationWest, HollywoodUSA
  5. 5.Society for Brain Mapping and TherapeuticsWest, HollywoodUSA

Personalised recommendations